Sarepta Therapeutics

Sarepta Therapeutics

Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

$2.2B

Market Cap • 9/11/2026

1980

(46 years)

Founded

1997

(29 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

1,4

P/S

1,1

P/EBITDA

P/OCF

19,5

P/FCF

26,5

P/E

BVPS

14,1

EPS

Market Cap

Market Cap

2,2B

EV

2,4B

EV/Revenue

1,2

EV/EBITDA

-24,6

EV/EBIT

-16,9

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-1%

Total Yield

-1%

Payout

0%

Retained Earnings

-4,6B

Profitability

Gross Margin

59,1%

EBITDA Margin

EBIT Margin

Net Margin

D&A/EBITDA

0%

R&D/Revenue

40%

Capex/Revenue

1,5%

Capex/D&A

65,2%

Capex/OCF

26,3%

SBC/OCF

22,9%

% PPE

14%

% Goodwill

0%

ROE

ROIC

Growth

CAGR Revenue 5Y

26,9%

CAGR Op. Income 5Y

-25,6%

CAGR Net Income 5Y

-26,4%

CAGR EPS 5Y

-18,4%

Leverage

N.D./EBITDA

Debt/Equity

0%

Current Ratio

4,4

Quick Ratio

2,3

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium